Business

At Illumina, the faster we can innovate, the more lives we can help save.  As a genomics pioneer, we have proven through focused and continued innovation how unlocking the power of the genome can exponentially improve the human condition. Our ability to drive patient outcomes has made us a trusted partner in healthcare. Today, we’re providing tools that enable the next generation of researchers and clinicians to usher in the future of personalized medicine. Innovating at the intersection of technology, biology, and health, we are re-imagining what’s possible for clinicians, transforming how they detect, diagnose, and treat cancer, and rare, infectious, and genetic diseases.

Videos from this campaign

Illumina at Dream Big
Illumina and Minderoo Foundation.

Content from this campaign

Health & Healthcare

Why More Clinical Labs Are Turning to Whole-Genome Sequencing for Cancer
Whole-genome sequencing (WGS) use is more established for rare and pediatric disease, but next-generation sequencing in clinical use for cancer consists of various approaches.

Health & Healthcare

Finding the Needle in the Genomic Haystack With DRAGEN
When scientists want to sequence a DNA sample on an Illumina system, they don’t try to read all 4 billion base pairs of the genome at once. Instead, they slice the DNA into short fragments of about 500 base pairs that are easier to work with and faster to read.

Health & Healthcare

Nucleus Genomics Wants To Make Personalized Health Care a Reality
Nucleus Genomics is realizing the dream set into motion long ago by the Human Genome Project: to use the power of genomics to help people live lives that are as healthy and long as possible.

Health & Healthcare

Why Pathogen Surveillance Is Critical During a “Tripledemic”
The 2022–23 “tripledemic” season—in which influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) all surged at the same time—was especially bad for Arizona, says Efrem Lim, an Arizona State University (ASU) virologist with the Center for Fundamental and Applied Microbiomics

Innovation & Technology

Highlights From Glasgow: Educating and Promoting the Impact of WGS
The Illumina NovaSeq X Plus took center stage at this year's European Society of Human Genetics (ESHG) conference in Glasgow, Scotland, considered Europe’s premier genomics event.

Innovation & Technology

What Our Primate Relatives Can Teach Us About Our Own Genomes
Each person’s genetic code harbors millions of variants that differ from one individual to the next, and account for differences in health and disease risk. The more human genomes are sequenced, the more data researchers have to compare and predict which variants are most likely.

Sustainable Finance & Socially Responsible Investment

Sequencing at Sea – Unlocking the Power of the Genome With eDNA and NextSeq™ 2000
In 2022, Illumina and Minderoo Foundation announced a $40M AUD partnership to leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions.

Responsible Business & Employee Engagement

Illumina Rings the Bell at Nasdaq
The Nasdaq closing bell in New York City signifies the end of a full day of trading on the stock market, a day of transactions made to benefit shareholders and companies, and propel business forward. Fittingly, Illumina representatives rang the closing bell on March 30.

Responsible Business & Employee Engagement

25 Greatest Impacts in 25 Years: Illumina and the Evolution of Genomics
This month, Illumina celebrates a quarter century of innovation, research, and passion. As a genomics pioneer founded in San Diego in 1998, we have proven—and continue to prove—how unlocking the power of the genome can exponentially improve the human condition.

Health & Healthcare

Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease
The Norwegian term for virgin snow, “nysnø”, seemed the appropriate inspiration to name Jennifer Johnston’s company, NysnoBio, as it underscores the pioneering work NysnoBio is doing to tap the potential of Parkin, the protein most often linked to young onset genetic Parkinson’s
Illumina logo

More from Illumina

  1. Access
    Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in...

  2. Community
    By sharing our time, talent, and technology, we aim to inspire, support, and empower our communities, our employees, and the next generation.

  3. Environment
    We are committed to integrating environmental stewardship into the way we operate. We recognize the importance of the environment in creating a...

  4. People
    Harnessing the world’s best talent and giving them the opportunity to thrive allows us to make world-changing leaps in human health and beyond. Our...

  5. Business
    At Illumina, the faster we can innovate, the more lives we can help save. As a genomics pioneer, we have proven through focused and continued...

  6. Operating Responsibly
    Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we...